Given the substantially greater risk of having clinical AD 8 and Aβ positivity 9 in homozygotes compared to heterozygotes, this supports recent work showing that statistical aggregation of APOE-ε4 homozygotes and heterozygotes in one group may not be appropriate 9. This evidence concerns the gene APOE and Alzheimer disease.